Clinical Trial Update: The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial update on tacrolimus for refractory rheumatoid arthritis examines efficacy and safety over 6 months with long-term treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Qiang Shu | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED